IDIOPATHIC PARKINSON DISEASE
Clinical trials for IDIOPATHIC PARKINSON DISEASE explained in plain language.
Never miss a new study
Get alerted when new IDIOPATHIC PARKINSON DISEASE trials appear
Sign up with your email to follow new studies for IDIOPATHIC PARKINSON DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Parkinson's patients try nutritional supplements to boost brain health
Symptom relief CompletedThis study looked at whether nutritional supplements, especially N-acetyl cysteine (NAC), could support brain function in people with Parkinson's disease. 51 adults with early-stage Parkinson's were randomly assigned to receive NAC (orally and intravenously), standard care, or ot…
Matched conditions: IDIOPATHIC PARKINSON DISEASE
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC
-
New drug VTX3232 shows promise for early Parkinson's safety
Symptom relief CompletedThis study tested whether a new drug called VTX3232 is safe for people with early-stage Parkinson's disease. Eleven participants took the drug for 28 days and were monitored for side effects. The goal was to see if the drug is well-tolerated and how it moves through the body.
Matched conditions: IDIOPATHIC PARKINSON DISEASE
Phase: PHASE2 • Sponsor: Zomagen Biosciences Ltd. • Aim: Symptom relief
Last updated May 12, 2026 13:40 UTC